CD34 and myelodysplastic syndrome: These deficits translate into decreased support of stem cell populations; in a long-term coculture with CD34+ hematopoietic stem and progenitor cells (HSPCs), MDS-derived MSCs compared with MSC controls had substantially reduced ability to provide HSPC support.